Bristol-Myers Squibb Company (NYSE: BMY) reaffirmed its 2008 earnings guidance for fully diluted earnings per share from continuing operations on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE